There is a vast pre-clinical literature suggesting that certain nutraceuticals have the potential
to aid the preservation of bone mass in the context of estrogen withdrawal, glucocorticoid …

The conceptualization of polycystic ovary syndrome (PCOS) has primarily focused on
hormonal alterations driven by changes within the hypothalamus and ovarian granulosa …

Prostate cancer (PCa) is the second most common type of cancer and the sixth cause of
death in men worldwide. Radiotherapy and immunotherapy are commonly used in treating …

Objective The study objective was to assess the therapeutic potential of Arsenic Trioxide
(ATO) and Flutamide combination for metastatic prostate cancer (PCa) treatment. Material …

Prostate cancer (PCa) is one of the most common male malignancies worldwide. In the
current study, we evaluated the effects of a natural deep eutectic solvent (NADES) extract of …

Background Although hormonal and metabolic dysfunction have been recognized as a
possible cause of polycystic ovarian syndrome (PCOS), the associations between …

Oxidative and dicarbonyl stress, driven by excess accumulation of glycolytic intermediates in
cells that are highly permeable to glucose in the absence of effective insulin activity, appear …

Prostate cancer (PC) represents the most common cancer disease in men. Since high levels
of androgens increase the risk of PC, androgen deprivation therapy is the primary treatment; …

Androgen (AR) signaling is the main signaling for the development of the prostate and its
normal functioning. AR is highly specific for testosterone and dihydrotestosterone …

Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder and the most
prevalent gynecological condition among women of reproductive age. Current treatment …